Leo Price

Leo Price has a diverse and extensive work experience in various scientific and leadership roles. Leo began their career as a PhD student at University College London and then went on to work as a postdoc at The Netherlands Cancer Institute and Scripps Research Institute. Leo furthered their research at UMC Utrecht before becoming a faculty member and group leader at Leiden University. In 2011, they became the CEO of OcellO, a CRO specializing in 3D tissue culture-based screening services. OcellO was later acquired by Crown Bioscience, where Leo served as the Senior Vice President and Global Head of In Vitro Operations. Currently, Leo holds the position of Senior Vice President of Corporate Innovation at JSR Life Sciences.

Leo Price earned a Ph.D. in Cell Physiology from University College London, starting in 1991 and completing the program in 1995.